TM vs TSV Implants Loaded Early vs Conventional in Anterior and Posterior Areas
NCT ID: NCT02158377
Last Updated: 2022-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2013-03-31
2020-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Conventional Dental Implants and Trabecular Metalâ„¢ Dental Implants After Sinus Floor Elevation
NCT02404649
Assessment of the Effect of a Novel Surface Roughness Treatment on Dental Implants on Integration Success
NCT01529801
A Clinical Study of the TSV Dental Implant System
NCT04236336
Evaluation of Immediate Versus Delayed Loading of Dental Implants With a Modified Surface
NCT00782171
T3 Certain Tapered With DCD vs T3 Certain Tapered Non-DCD
NCT04354688
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tapered Screw-vent implants (TSV)
TSV implants to replace missing tooth/teeth
Tapered screw-vent implants (TSV)
Patients receive TSV dental implants in this arm. The early stability is measured and compared to the stability of the TM implants. The implants are loaded and provisionalized early at 3 or 6 weeks if stability permits.
Trabecular Metal dental implants (TM)
TM dental implants to replace missing tooth/teeth
Trabecular metal dental implants (TM)
Patients receive TM dental implants in this arm. The early stability is measured and compared to the stability of the TSV implants. The implants are loaded and provisionalized early at 3 or 6 weeks if stability permits.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Trabecular metal dental implants (TM)
Patients receive TM dental implants in this arm. The early stability is measured and compared to the stability of the TSV implants. The implants are loaded and provisionalized early at 3 or 6 weeks if stability permits.
Tapered screw-vent implants (TSV)
Patients receive TSV dental implants in this arm. The early stability is measured and compared to the stability of the TM implants. The implants are loaded and provisionalized early at 3 or 6 weeks if stability permits.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Provide a voluntarily signed Informed Consent
3. Must be 18 years or older
4. Have one or more edentulous area(s) in the posterior maxilla or mandible designated for an implant supported restoration
5. The implantation site must have a functional antagonist to obtain full occlusion.
6. Implants adjacent to planned site of implantation should have been in function for at least 1 year.
7. The site intended for implant placement should have healed for at least 4 months from the time of extraction or at least 6 months from any other bone augmentation procedures.
8. The site intended for implant placement should have adequate bone volume to support an implant without the need for augmentation except for minor dehiscence (limited to a vertical height of 2mm), which can be augmented with autogenous bone chips to improve soft tissue attachment.
9. The site intended for implant placement should have residual facial and palatal/lingual plates to be at least 1.0mm thick after implant placement.
10. The site intended for implant placement should have vertical bone volume to extend at least 2.0mm apical to the implant after implant placement.
Exclusion Criteria
2. Smokers, alcoholics or drug abusers
3. Subjects with systemic conditions such as uncontrolled diabetes, endocrine disorders, heart disease, immune-compromised subjects or mental disorders
4. Use of concurrent medication which inhibits bone metabolism like bisphosphonates, corticosteroids or methotrexate
5. Bleeding disorders and/or anticoagulant therapy
6. Pregnancy
7. Known sensitivity or allergy to any of the implant materials
8. Subjects with bruxism or clenching habits
9. Uncontrolled periodontal or oral pathologies (e.g. mucosal disease, oral lesions)
10. Inadequate oral hygiene
11. History of radiation at the site intended for study implant placement
12. Subjects who have previously failed dental implants at the site intended for study implant placement
13. Subjects participating in another clinical study
14. Subjects who need other surgeries in a site adjacent to the study implant(s)
15. Subjects who need other surgeries in a site non-adjacent to the study implant(s) within 6 months of study implant placement
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ZimVie
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wilfried Wagner
Role: PRINCIPAL_INVESTIGATOR
Universitatsbedizin Mainz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitat Regensburg
Regensburg, Bavaria, Germany
Heinrich Heine Universitat Dusseldorf
Düsseldorf, Nordhein-Westfalen, Germany
Universitatsmedizin Mainz
Mainz, Rhineland-Palatinate, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSU2011-08D
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.